1[1]Blezinger P,Wang J,Gondo M,et al.Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene[J].Nat Biotechnol,1999,17(4):343-348.
2[2]Arenberg DA,Kunkel SL,Polverini PJ,et al.Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases[J].J Exp Med,1996,184(3):981-982.
3[3]Shalinsky DR,Brekken J,Zou H,et al.Broad antitumor and antiangiogenic activities of AG3340,a potent and selective MMP inhibitor undergoing advanced oncology clinical trials[J].Ann N Y Acad Sci,1999,878(2):236-270.
4[4]Lozonschi L,Sunamura M,Kobari M,et al.Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor,KB-R7785,in two tumor models[J].Cancer Res,1999,59(6):1252-1258.
5[5]Fontanini G,Vignati S,Lucchi M,et al.Neoangiogenesis and p53 protein in lung cancer:their prognostic role and their relation with vascular endothelial growth factor(VEGF) expression[J].Br J Cancer,1997,75(9):1295-1301.
6[6]Nishizaki M,Fujiwara T,Tanida T,et al.Recombinant adenovirus expressing wild-type p53 is antiangiogenic:a proposed mechanism for bystander effect[J].Clin Cancer Res,1999,5(5):1015-1023.
7[7]Arenberg DA,Polverini PJ,Kunkel SL,et al.The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer[J].J Leukoc Biol,1997,62(5):554-562.
8[8]Miki T,Nonomura N,Nozawa M,et al.Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line[J].J Urol,1998,160(1):210-213.
9[9]Hatanaka H,Oshika Y,Abe Y,et al.Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1)[J].Int J Mol Med,2000,5(2):181-183.
10[10]Huang S,Xie K,Bucana CD,et al.Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells:potential inhibition of angiogenesis[J].Clin Cancer Res,1996,2(12):1969-1979.
同被引文献13
1Wisnivesky JP, Mushlin AI, Sicherman N,et al. The cost- effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest, 2003,124(2) : 614-621.
2Burtscher IM, Holtas S. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging,2001,13(4) : 560-567.
3Van Zandwijk N. New methods for early diagnosis of lung cancer. Lung Cancer, 2002,38(1): S9-11.
4Folkman J, Beckner K. Angiogenesis imaging. Acad Radiol,2000,7(10) : 783-785.
5Safriel Y, Zinn H. CT pulmonary angiography in the detection of pulmonary emboli: a meta-analysis of sensitivities and speci ficities. Clin Imaging, 2002, 26 (2) : 101-105.
6Ciccotosto C, Goodman LR, Washington L, et al. Indirect CT venography following CT pulmonary angiography: spectrum of CT findings. J Thorac Imaging. 2002,17(1): 18-27.
7Rapp-Bernhardt U, Welte T, Doehring W,et al. Diagnostic potential of virtual bronchoscopy: advantages in comparison with axial CT slices, MPR and mIP? Eur Radiol,2000,10(6): 981-988.
8Tateishi U, Nishihara H, Watanabe S, et al. Tumor angiogenesis and dynamic CT in lung adenocarcinoma: radiologic-pathologic correlation. J Comput Assist Tomogr,2001,25(1) : 23-27.
9Bloomgarden DC, Rosen MP. Newer diagnostic modalities for pulmonary embolism.Pulmonary angiography using CT and MR imaging compared with conventional angiography. Emerg Med Clin North Am,2001,19(4) : 975-994.
